InVivo Therapeutics (NSDQ:NVIV) said today that it enrolled a new patient in the Inspire study of its neuro-spinal scaffold.
Principal investigator Dr. Travis Dumont performed the implantation earlier this week, 67 hours after the patient’s spinal cord injury happened.
“The implantation procedure of the neuro-spinal scaffold was successful, and the patient is doing well,” Dumont said in prepared remarks. “I look forward to following the patient’s progress going forward.”
